Jennifer Carew, PhD

Associate Professor, Medicine
Co-Director, Hematologic Malignancy Disease Team
Email Address: 
Phone Number: 
(520) 626-2272
Professional Bio: 
  • Translational cancer researcher with expertise in experimental cancer therapeutics, mechanisms of cell death and drug resistance, in vitro and in vivo preclinical investigation of developmental cancer therapeutics, Phase I clinical trial design, and clinical trial correlates
  • 15 years of research experience in basic and translational hematology and oncology
  • 6 years of experience as the Co-Director of a contract research organization laboratory evaluating the preclinical activity and mechanism of action of novel cancer therapeutics in cell lines, primary patient specimens, and mouse models of cancer
  • Track record of strong industry collaborations focused on investigational drugs, strategies to translate preclinical findings into clinical trials, and development of rational correlative studies in support of clinical trials
  • Patent inventor of novel anticancer agents

Research Information

Selected Publications: 

Professional Information

Positions and Honors: 
  • Leukemia and Lymphoma Society Scholar, 2012
  • Voelcker Fund Young Investigator Award, 2012
  • Leukemia Texas Young Investigator Award, 2008
  • American Cancer Society Postdoctoral Research Award, 2007
  • Sowell-Huggins Endowed Scholarship for Cancer Research, 2005
  • University of Texas Health Science Center and M.D. Anderson Cancer Center Presidents’ Research
  • Scholarship, 2005
  • American Legion Auxiliary Fellowship for Cancer Research, 2003-2005
  • Shell Oil Foundation Scholarship for Excellence in Toxicology Research, 2003
  • Edward S. Reynolds Award for Best Platform Presentation, Gulf Coast Society of Toxicology Annual
  • Meeting, 2003
  • Gulf Coast Society of Toxicology Travel Award, 2003
  • Society of Toxicology Travel Award, 2003
Other Experience and Professional Memberships/Affiliations: 
US Patent #8,524,762 B2 – Thioxanthone-based autophagy inhibitor therapies to treat cancer
US Patent Filed 07/2014 – Novel autophagy inhibitors for cancer therapy
American Association for Cancer Research
American Society of Hematology
European Hematology Association

Academic Information

Biomedical Sciences, University of Texas M.D. Anderson Cancer Center, Houston, Tx
Undergraduate School: 
BS, Zoology, University of Wisconsin – Madison